Eton Pharmaceuticals (ETON) delivered earnings and revenue surprises of 0% and 9.05%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
These figures are adjusted for non-recurring items ... Apellis Pharmaceuticals , which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $212.53 million for ...
Jazz Pharmaceuticals (JAZZ ... These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 13.99%. A quarter ago, it was expected that this ...
Zacks.com on MSN21d
Syndax Pharmaceuticals (SNDX) Reports Q4 Loss, Lags Revenue EstimatesSyndax (SNDX) delivered earnings and revenue surprises of -1.85% and 65.45%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Hello, and welcome to Mirum Pharmaceuticals Reports Fourth Quarter ... aligns well with the capabilities we have built in rare genetic neurology for the launch of CTEXLI. Pulling all this together ...
Kennedy Jr., who was tapped to lead the Department of Health and Human Services for the Trump administration, recently ...
A Special Meeting of Shareholders in Gentoo Media Inc. (the "Company") was held today, 13 March 2025, in Stockholm, Sweden. Shareholders representing 51.18% of the shares entitled to vote were present ...
We may earn commission on some of the items you choose to buy ... people drop even more weight—and could help biotech and pharmaceutical companies make a killing in a market that’s predicted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results